Predictive Technology Group is a life science company based in Salt Lake City, founded in 2005.

Predictive Laboratories Announces its Assurance AB™ COVID-19 IgM/IgG Rapid Antibody Test for Use by Laboratories and Healthcare Workers at the Point-of-Care

ASSURANCE AB™ is a rapid test developed to detect the presence of IgM and/or IgG antibodies associated with the SARS-CoV-2 virus. ASSURANCE AB™ is a single-use, self-contained test that requires a small sample of the patient’s blood, collected via fingerstick. Results appear on testing device within 15 minutes. The results indicate the presence of antibodies, developed in response to the SARS-CoV-2 virus associated with the COVID-19 pandemic. The test will be available in all 50 states across the U.S. through Predictive’s distribution partner, Wellgistics.

See Newsroom for further announcements.

Please visit Assurance AB™ for more information.

Predictive Technology Group is dedicated to helping women and their clinicians identify the barriers that impact lifelong health through our genetic library, genomic mapping and individualized diagnostics. We are committed to building healthier families through our innovations in bioscience to deliver on personalized medicine.

Predictive Technology Group Announces Initial Order of One Million Units of the Assurance AB™ COVID-19 IgM/IgG Rapid Antibody Test from Distribution Partner, Wellgistics, LLC.

“We have been working diligently with Wellgistics to get this first order put in motion, even prior to making our partnership announcement on April 3,” said Bradley Robinson, CEO of Predictive Technology Group. “This country is in high need of the Assurance AB testing for point of care use and we have brought all resources to bear to bring this product to the United States. Wellgistics has provided us with state-by-state demand guidance, to ensure that regions with the most urgent need have first access to the test. Our main priorities will be to focus on servicing those areas,” Robinson continued.

View the Press Release

Predictive Technology Group Announces Distribution Agreement with Wellgistics, LLC for Its Assurance AB™ COVID-19 IgM/IgG Rapid Antibody Test for Use by Laboratories and Healthcare Workers at the Point-of-Care

“We are pleased to partner with Wellgistics. They are an ideal partner and are able to scale and serve the most critical needs in the face of this global pandemic. Wellgistics’ logistics, expertise and infrastructure has demonstrated the ability to efficiently move products from around the world to the U.S. market and was an important component in our decision to partner with them. We are in production in advance of Wellgistic’s purchase orders and will update stakeholders on details over the next few days,” said Bradley Robinson, CEO of Predictive Technology Group. “We will support Wellgistics, their team and customers with Predictive Laboratories’ full scientific, operational and service team members,” added Robinson.

View the Press Release

Newsroom

To keep up on all news about Predictive Technology Group, click the link below.

View the Newsroom